HBIO

HBIO Volume Jumps 3.1x as Analyst Raises Price Target to $7.5

HBIO volume surged 3.1x average after a post-earnings price-target hike, but a 928% debt ratio and -173% ROE make this an unclassified small-cap watchlist name, not a clear buy.